ARYAN AI secures $3M to expand its wet-lab validation loopPlaceholder
New funding strengthens the connection between our models and the bench, adding assay capacity so every design cycle is tested faster.
ARYAN AI Drug Discovery has raised a total of $3M to date. The capital is being directed to the part of the platform that matters most for credibility: experimental validation.
Every molecule or target our models propose is only as good as the data that confirms it. The investment increases assay throughput in our laboratory, so results flow back into the models within days rather than weeks.
The funding also supports continued investment in sovereign compute and data infrastructure, keeping partner and proprietary data under our full control.